News
Latest News
-
Watch for It: TransCon® hGH Enhances TransCon® CNP Benefits in Achondroplasia (Week 26 COACH Trial)
Watch for peer-reviewed paper on TransCon® hGH Boosted Treatment Benefits of TransCon® CNP in Children with Achondroplasia at Week 26 Interim Analysis of the Phase 2 COACH Trial
-
Watch for It: BridgeBio Reports First Significant Body Proportionality Improvements in Achondroplasia Trial
Watch for peer-reviewed paper on BridgeBio Reports Positive Phase 3 Topline Results for Oral Infigratinib with the First Statistically Significant Improvements in Body Proportionality in Achondroplasia
-
Join Us for the 17th International Skeletal Dysplasia Society Meeting
Toronto, Ontario, Canada | August 26–29, 2026 | The Hospital for Sick Children (SickKids)
